<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39401061</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2057-5858</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Microbial genomics</Title><ISOAbbreviation>Microb Genom</ISOAbbreviation></Journal><ArticleTitle>The Canadian VirusSeq Data Portal and Duotang: open resources for SARS-CoV-2 viral sequences and genomic epidemiology.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">001293</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1099/mgen.0.001293</ELocationID><Abstract><AbstractText>The COVID-19 pandemic led to a large global effort to sequence SARS-CoV-2 genomes from patient samples to track viral evolution and inform the public health response. Millions of SARS-CoV-2 genome sequences have been deposited in global public repositories. The Canadian COVID-19 Genomics Network (CanCOGeN - VirusSeq), a consortium tasked with coordinating expanded sequencing of SARS-CoV-2 genomes across Canada early in the pandemic, created the Canadian VirusSeq Data Portal, with associated data pipelines and procedures, to support these efforts. The goal of VirusSeq was to allow open access to Canadian SARS-CoV-2 genomic sequences and enhanced, standardized contextual data that were unavailable in other repositories and that meet FAIR standards (Findable, Accessible, Interoperable and Reusable). In addition, the portal data submission pipeline contains data quality checking procedures and appropriate acknowledgement of data generators that encourages collaboration. From inception to execution, the portal was developed with a conscientious focus on strong data governance principles and practices. Extensive efforts ensured a commitment to Canadian privacy laws, data security standards, and organizational processes. This portal has been coupled with other resources, such as Viral AI, and was further leveraged by the Coronavirus Variants Rapid Response Network (CoVaRR-Net) to produce a suite of continually updated analytical tools and notebooks. Here we highlight this portal (https://virusseq-dataportal.ca/), including its contextual data not available elsewhere, and the Duotang (https://covarr-net.github.io/duotang/duotang.html), a web platform that presents key genomic epidemiology and modelling analyses on circulating and emerging SARS-CoV-2 variants in Canada. Duotang presents dynamic changes in variant composition of SARS-CoV-2 in Canada and by province, estimates variant growth, and displays complementary interactive visualizations, with a text overview of the current situation. The VirusSeq Data Portal and Duotang resources, alongside additional analyses and resources computed from the portal (COVID-MVP, CoVizu), are all open source and freely available. Together, they provide an updated picture of SARS-CoV-2 evolution to spur scientific discussions, inform public discourse, and support communication with and within public health authorities. They also serve as a framework for other jurisdictions interested in open, collaborative sequence data sharing and analyses.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gill</LastName><ForeName>Erin E</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Baofeng</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murall</LastName><ForeName>Carmen Lia</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poujol</LastName><ForeName>Raphaël</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Research Centre, Montréal Heart Institute, Montréal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anwar</LastName><ForeName>Muhammad Zohaib</ForeName><Initials>MZ</Initials><AffiliationInfo><Affiliation>Centre for Infectious Disease Genomics and One Health, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>John</LastName><ForeName>Nithu Sara</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Centre for Infectious Disease Genomics and One Health, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richardsson</LastName><ForeName>Justin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Ontario Institute for Cancer Research, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hobb</LastName><ForeName>Ashley</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>DNAstack, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olabode</LastName><ForeName>Abayomi S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lepsa</LastName><ForeName>Alexandru</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ontario Institute for Cancer Research, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duggan</LastName><ForeName>Ana T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tyler</LastName><ForeName>Andrea D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>N'Guessan</LastName><ForeName>Arnaud</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>McGill Genome Centre, McGill University, Montréal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Département de Biochimie et Médecine Moléculaire, Université de Montréal, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kachru</LastName><ForeName>Atul</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ontario Institute for Cancer Research, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Brandon</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Ontario Institute for Cancer Research, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshida</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yung</LastName><ForeName>Christina K</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Indoc Systems, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ontario Institute for Cancer Research, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bujold</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Human Genetics, McGill University, Montréal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Canadian Centre for Computational Genomics, Montréal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andric</LastName><ForeName>Dusan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Ontario Institute for Cancer Research, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Edmund</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Ontario Institute for Cancer Research, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Griffiths</LastName><ForeName>Emma J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Centre for Infectious Disease Genomics and One Health, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Domselaar</LastName><ForeName>Gary</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jolly</LastName><ForeName>Gordon W</ForeName><Initials>GW</Initials><AffiliationInfo><Affiliation>National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ward</LastName><ForeName>Heather K E</ForeName><Initials>HKE</Initials><AffiliationInfo><Affiliation>DNAstack, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feher</LastName><ForeName>Henrich</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Ontario Institute for Cancer Research, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baker</LastName><ForeName>Jared</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Ontario Institute for Cancer Research, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simpson</LastName><ForeName>Jared T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Ontario Institute for Cancer Research, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uddin</LastName><ForeName>Jaser</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Ontario Institute for Cancer Research, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ragoussis</LastName><ForeName>Jiannis</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>McGill Genome Centre, McGill University, Montréal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eubank</LastName><ForeName>Jon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Ontario Institute for Cancer Research, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fritz</LastName><ForeName>Jörg H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, McGill Research Center on Complex Traits (MRCCT), Dahdaleh Institute of Genomic Medicine (DIGM), McGill University, Montréal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gálvez</LastName><ForeName>José Héctor</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Ontario Institute for Cancer Research, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>DNAstack, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cullion</LastName><ForeName>Kim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Ontario Institute for Cancer Research, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivera</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Ontario Institute for Cancer Research, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiang</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Ontario Institute for Cancer Research, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Croxen</LastName><ForeName>Matthew A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Alberta Precision Laboratories, Public Health Laboratory, Edmonton, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Li Ka Shing Institute of Virology, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Women and Children's Health Research Institute, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shiell</LastName><ForeName>Mitchell</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ontario Institute for Cancer Research, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prystajecky</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quirion</LastName><ForeName>Pierre-Olivier</ForeName><Initials>PO</Initials><AffiliationInfo><Affiliation>Canadian Centre for Computational Genomics, Montréal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bajari</LastName><ForeName>Rosita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Ontario Institute for Cancer Research, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rich</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Ontario Institute for Cancer Research, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mubareka</LastName><ForeName>Samira</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sunnybrook Research Institute, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreira</LastName><ForeName>Sandrine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Université de Montréal, Montréal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cain</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Ontario Institute for Cancer Research, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sutcliffe</LastName><ForeName>Steven G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, McGill University, Montréal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kraemer</LastName><ForeName>Susanne A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>McGill Genome Centre, McGill University, Montréal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aquatic Contaminants Research Division, ECCC, Montréal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alturmessov</LastName><ForeName>Yelizar</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Ontario Institute for Cancer Research, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joly</LastName><ForeName>Yann</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Centre of Genomics and Policy, McGill University, Montréal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cphln Consortium</LastName></Author><Author ValidYN="Y"><LastName>CanCOGeN Consortium</LastName></Author><Author ValidYN="Y"><LastName>VirusSeq Data Portal Academic And Health Network</LastName></Author><Author ValidYN="Y"><LastName>Fiume</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>DNAstack, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Snutch</LastName><ForeName>Terrance P</ForeName><Initials>TP</Initials><AffiliationInfo><Affiliation>Michael Smith Laboratories and Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bell</LastName><ForeName>Cindy</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Genome Canada, 150 Metcalfe Street, Suite 2100, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Correa</LastName><ForeName>Catalina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Genome Canada, 150 Metcalfe Street, Suite 2100, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussin</LastName><ForeName>Julie G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Research Centre, Montréal Heart Institute, Montréal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mila-Québec AI institute, Montréal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Département de Biochimie et Médecine Moléculaire, Université de Montréal, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joy</LastName><ForeName>Jeffrey B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Molecular Epidemiology and Evolutionary Genetics, BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bioinformatics Programme, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colijn</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Mathematics, Simon Fraser University, Burnaby, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gordon</LastName><ForeName>Paul M K</ForeName><Initials>PMK</Initials><AffiliationInfo><Affiliation>Centre for Health Genomics and Informatics, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsiao</LastName><ForeName>William W L</ForeName><Initials>WWL</Initials><AffiliationInfo><Affiliation>Centre for Infectious Disease Genomics and One Health, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poon</LastName><ForeName>Art F Y</ForeName><Initials>AFY</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Western University, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knox</LastName><ForeName>Natalie C</ForeName><Initials>NC</Initials><AffiliationInfo><Affiliation>National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Courtot</LastName><ForeName>Mélanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical BioPhysics, University of Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ontario Institute for Cancer Research, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stein</LastName><ForeName>Lincoln</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Ontario Institute for Cancer Research, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otto</LastName><ForeName>Sarah P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Zoology and Biodiversity Research Centre, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bourque</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Human Genetics, McGill University, Montréal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Canadian Centre for Computational Genomics, Montréal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shapiro</LastName><ForeName>B Jesse</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, McGill University, Montréal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brinkman</LastName><ForeName>Fiona S L</ForeName><Initials>FSL</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U24 CA253529</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Microb Genom</MedlineTA><NlmUniqueID>101671820</NlmUniqueID><ISSNLinking>2057-5858</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>ArXiv. 2024 May 8:arXiv:2405.04734v1.</RefSource><PMID Version="1">38764594</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016679" MajorTopicYN="Y">Genome, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="N">Genomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030541" MajorTopicYN="N">Databases, Genetic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">data sharing</Keyword><Keyword MajorTopicYN="N">evolutionary biology</Keyword><Keyword MajorTopicYN="N">mutational analysis</Keyword><Keyword MajorTopicYN="N">open access</Keyword><Keyword MajorTopicYN="N">viral genomics</Keyword></KeywordList><CoiStatement>J.T.S. receives research funding from Oxford Nanopore Technologies (ONT) and has received travel support to attend and speak at meetings organized by ONT, and is on the Scientific Advisory Board of Day Zero Diagnostics.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>12</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>11</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39401061</ArticleId><ArticleId IdType="pmc">PMC11472881</ArticleId><ArticleId IdType="doi">10.1099/mgen.0.001293</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cameron R, Savić-Kallesøe S, Griffiths EJ, Dooley D, Sridhar A, et al.  SARS-CoV-2 genomic contextual data harmonization: recommendations from a mixed methods analysis of COVID-19 case report forms across Canada. 2022.  [9-April-2024]. https://www.researchsquare.com/article/rs-1871614/v1 accessed.</Citation></Reference><Reference><Citation>Shu Y, McCauley J. GISAID: global initiative on sharing all influenza data – from vision to reality. Eurosurveillance. 2017;22:30494. doi: 10.2807/1560-7917.ES.2017.22.13.30494.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2017.22.13.30494</ArticleId><ArticleId IdType="pmc">PMC5388101</ArticleId><ArticleId IdType="pubmed">28382917</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare S, Gurry C, Freitas L, Schultz MB, Bach G, et al. GISAID’s role in pandemic response. China CDC Wkly. 2021;3:1049–1051. doi: 10.46234/ccdcw2021.255.</Citation><ArticleIdList><ArticleId IdType="doi">10.46234/ccdcw2021.255</ArticleId><ArticleId IdType="pmc">PMC8668406</ArticleId><ArticleId IdType="pubmed">34934514</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbe S, Buckland‐Merrett G. Data, disease and diplomacy: GISAID’s innovative contribution to global health. Global Challenges . 2017;1:33–46. doi: 10.1002/gch2.1018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gch2.1018</ArticleId><ArticleId IdType="pmc">PMC6607375</ArticleId><ArticleId IdType="pubmed">31565258</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalia K, Saberwal G, Sharma G. The lag in SARS-CoV-2 genome submissions to GISAID. Nat Biotechnol. 2021;39:1058–1060. doi: 10.1038/s41587-021-01040-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-021-01040-0</ArticleId><ArticleId IdType="pubmed">34376850</ArticleId></ArticleIdList></Reference><Reference><Citation>Enserink M, Cohen J. Control issues. Science. 2023;380:332–339. doi: 10.1126/science.adi4114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.adi4114</ArticleId><ArticleId IdType="pubmed">37104578</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenharo M. GISAID in crisis: can the controversial COVID genome database survive? Nature. 2023;617:455–457. doi: 10.1038/d41586-023-01517-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-023-01517-9</ArticleId><ArticleId IdType="pubmed">37142725</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill IS, Griffiths EJ, Dooley D, Cameron R, Savić Kallesøe S, et al. The DataHarmonizer: a tool for faster data harmonization, validation, aggregation and analysis of pathogen genomics contextual information. Microb Genom. 2023;9:mgen000908. doi: 10.1099/mgen.0.000908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/mgen.0.000908</ArticleId><ArticleId IdType="pmc">PMC9973856</ArticleId><ArticleId IdType="pubmed">36748616</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman N, O’Cathail C, Zyoud A, Sokolov A, Oude Munnink B, et al. Mobilisation and analyses of publicly available SARS-CoV-2 data for pandemic responses. Microb Genom. 2024;10:001188. doi: 10.1099/mgen.0.001188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/mgen.0.001188</ArticleId><ArticleId IdType="pmc">PMC10926692</ArticleId><ArticleId IdType="pubmed">38358325</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EA, Libuit KG, Kapsak CJ, Scribner MR, Wright SM, et al. Pathogen genomics in public health laboratories: successes, challenges, and lessons learned from California’s SARS-CoV-2 Whole-Genome Sequencing Initiative, California COVIDNet. Microb Genom. 2023;9:mgen001027. doi: 10.1099/mgen.0.001027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/mgen.0.001027</ArticleId><ArticleId IdType="pmc">PMC10327507</ArticleId><ArticleId IdType="pubmed">37267020</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths EJ, Timme RE, Mendes CI, Page AJ, Alikhan N-F, et al. Future-proofing and maximizing the utility of metadata: the PHA4GE SARS-CoV-2 contextual data specification package. GigaScience . 2022;11:giac003. doi: 10.1093/gigascience/giac003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gigascience/giac003</ArticleId><ArticleId IdType="pmc">PMC8847733</ArticleId><ArticleId IdType="pubmed">35169842</ArticleId></ArticleIdList></Reference><Reference><Citation>Virological. Monitoring the evolution and spread of Delta sublineages AY.25 and AY.27 in Canada - SARS-CoV-2 coronavirus / nCoV-2019 Genomic Epidemiology. 2021.  [9-April-2024]. https://virological.org/t/monitoring-the-evolution-and-spread-of-delta-sublineages-ay-25-and-ay-27-in-canada/767 accessed.</Citation></Reference><Reference><Citation>Steiner MC, Novembre J. Population genetic models for the spatial spread of adaptive variants: a review in light of SARS-CoV-2 evolution. PLoS Genet. 2022;18:e1010391. doi: 10.1371/journal.pgen.1010391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1010391</ArticleId><ArticleId IdType="pmc">PMC9498967</ArticleId><ArticleId IdType="pubmed">36137003</ArticleId></ArticleIdList></Reference><Reference><Citation>Overture - Home.  [9-April-2024]. https://www.overture.bio/ n.d. accessed.</Citation></Reference><Reference><Citation>Keycloak.  [9-April-2024]. https://www.keycloak.org/ n.d. accessed.</Citation></Reference><Reference><Citation>Viral AI, DNAstack.  [9-April-2024]. https://viral.ai/collections/virusseq/overview n.d. accessed.</Citation></Reference><Reference><Citation>O’Toole Á, Pybus OG, Abram ME, Kelly EJ, Rambaut A. Pango lineage designation and assignment using SARS-CoV-2 spike gene nucleotide sequences. BMC Genom. 2022;23:121. doi: 10.1186/s12864-022-08358-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12864-022-08358-2</ArticleId><ArticleId IdType="pmc">PMC8832810</ArticleId><ArticleId IdType="pubmed">35148677</ArticleId></ArticleIdList></Reference><Reference><Citation>Turakhia Y, Thornlow B, Hinrichs AS, De Maio N, Gozashti L, et al. Ultrafast Sample placement on Existing tRees (UShER) enables real-time phylogenetics for the SARS-CoV-2 pandemic. Nat Genet. 2021;53:809–816. doi: 10.1038/s41588-021-00862-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00862-7</ArticleId><ArticleId IdType="pmc">PMC9248294</ArticleId><ArticleId IdType="pubmed">33972780</ArticleId></ArticleIdList></Reference><Reference><Citation>Anwar MZ, Gill IS, Iseminger M, Sehar A, Igwacho KD, et al. COVID-MVP: an interactive visualization for tracking SARS-cov-2 mutations, variants, and prevalence, enabled by curated functional annotations and portable genomics workflow. bioRxiv. 2022 doi: 10.1101/2022.06.07.493653v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.07.493653v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Canada PHA of. Health Infobase - Health data in Canada. 2013.  [9-April-2024]. https://health-infobase.canada.ca/ accessed.</Citation></Reference><Reference><Citation>Liyanage K, Samarakoon H, Parameswaran S, Gamaarachchi H. Efficient end-to-end long-read sequence mapping using minimap2-fpga integrated with hardware accelerated chaining. Sci Rep. 2023;13:20174. doi: 10.1038/s41598-023-47354-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-47354-8</ArticleId><ArticleId IdType="pmc">PMC10656460</ArticleId><ArticleId IdType="pubmed">37978244</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira R-C, Wong E, Gugan G, Wade K, Liu M, et al. CoVizu: rapid analysis and visualization of the global diversity of SARS-CoV-2 genomes. Virus Evol. 2021;7:veab092. doi: 10.1093/ve/veab092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veab092</ArticleId><ArticleId IdType="pmc">PMC10131274</ArticleId><ArticleId IdType="pubmed">37124703</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen L-T, Schmidt HA, von Haeseler A, Minh BQ. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol Biol Evol. 2015;32:268–274. doi: 10.1093/molbev/msu300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msu300</ArticleId><ArticleId IdType="pmc">PMC4271533</ArticleId><ArticleId IdType="pubmed">25371430</ArticleId></ArticleIdList></Reference><Reference><Citation>CIBIV - Center for Integrative Bioinformatics Vienna; 2024.  [9-April-2024]. Cibiv/IQ-TREE.https://github.com/Cibiv/IQ-TREE accessed.</Citation></Reference><Reference><Citation>Sagulenko P, Puller V, Neher RA. TreeTime: maximum-likelihood phylodynamic analysis. Virus Evol. 2018;4:vex042. doi: 10.1093/ve/vex042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/vex042</ArticleId><ArticleId IdType="pmc">PMC5758920</ArticleId><ArticleId IdType="pubmed">29340210</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon A. ArtPoon/ggfree. 2024.  [9-April-2024]. https://github.com/ArtPoon/ggfree accessed.</Citation></Reference><Reference><Citation>RStudio; 2024.  [9-April-2024]. rstudio/r2d3.https://github.com/rstudio/r2d3 accessed.</Citation></Reference><Reference><Citation>Plotly; 2024.  [9-April-2024]. plotly/plotly.R.https://github.com/plotly/plotly.R accessed.</Citation></Reference><Reference><Citation>Neher RA. Contributions of adaptation and purifying selection to SARS-CoV-2 evolution. Virus Evol. 2022;8:veac113. doi: 10.1093/ve/veac113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veac113</ArticleId><ArticleId IdType="pmc">PMC10431346</ArticleId><ArticleId IdType="pubmed">37593203</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Nadeau S, Yared M, Voinov P, Xie N, et al. CoV-Spectrum: analysis of globally shared SARS-CoV-2 data to identify and characterize new variants. Bioinformatics. 2022;38:1735–1737. doi: 10.1093/bioinformatics/btab856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btab856</ArticleId><ArticleId IdType="pmc">PMC8896605</ArticleId><ArticleId IdType="pubmed">34954792</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolker [aut B, cre, Team RDC, Giné-Vázquez I. bbmle: Tools for General Maximum Likelihood Estimation. 2023.  [9-April-2024]. https://cran.r-project.org/web/packages/bbmle/index.html accessed.</Citation></Reference><Reference><Citation>RandomFromHessianOrMCMC function - RDocumentation.  [9-April-2024]. https://www.rdocumentation.org/packages/HelpersMG/versions/5.1/topics/RandomFromHessianOrMCMC n.d. accessed.</Citation></Reference><Reference><Citation>Respiratory virus dashboard.  [9-April-2024]. https://www.alberta.ca/covid-19-alberta-data.aspx n.d. accessed.</Citation></Reference><Reference><Citation>Gouvernement du Québec.  [9-April-2024]. https://www.quebec.ca/en/health/health-issues/a-z/2019-coronavirus/situation-coronavirus-in-quebec n.d. accessed.</Citation></Reference><Reference><Citation>Population and demography statistics.  [9-April-2024]. https://www.statcan.gc.ca/en/subjects-start/population_and_demography n.d. accessed.</Citation></Reference><Reference><Citation>Song L, Liu H, Brinkman FSL, Gill E, Griffiths EJ, et al. Addressing privacy concerns in sharing viral sequences and minimum contextual data in a public repository during the COVID-19 pandemic. Front Genet. 2021;12:716541. doi: 10.3389/fgene.2021.716541.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2021.716541</ArticleId><ArticleId IdType="pmc">PMC8988250</ArticleId><ArticleId IdType="pubmed">35401651</ArticleId></ArticleIdList></Reference><Reference><Citation>Savic Kallesoe SA, Rabbani T, Gill EE, Brinkman F, Griffiths EJ, et al. Canadians’ opinions towards COVID-19 data-sharing: a national cross-sectional survey. BMJ Open. 2023;13:e066418. doi: 10.1136/bmjopen-2022-066418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-066418</ArticleId><ArticleId IdType="pmc">PMC9905784</ArticleId><ArticleId IdType="pubmed">36750286</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabbani T, Kallesøe SAS, Gill EE, Brinkman FSL, Griffiths EJ, et al.   Popul Med;  [23-April-2024]. Opinions matter: public opinions on data-sharing and how they can shape pathogen genomic surveillance in Canada.https://www.populationmedicine.eu/Opinions-matter-public-opinions-on-data-sharing-and-how-they-can-shape-pathogen-genomic,163811,0,2.html n.d. accessed.</Citation></Reference><Reference><Citation>Christoffels A, Mboowa G, van Heusden P, Makhubela S, Githinji G, et al. A pan-African pathogen genomics data sharing platform to support disease outbreaks. Nat Med. 2023;29:1052–1055. doi: 10.1038/s41591-023-02266-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02266-y</ArticleId><ArticleId IdType="pubmed">37161068</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofonea MT, Roquebert B, Foulongne V, Morquin D, Verdurme L, et al.  Analyzing and modeling the spread of SARS-CoV-2 omicron lineages BA.1 and BA.2, France, September 2021–February 2022 - Volume 28, Number 7—July 2022-- Emerging Infectious Diseases Journal - CDC.  [8-August-2024]. https://wwwnc.cdc.gov/eid/article/28/7/22-0033_article n.d. accessed.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9239895</ArticleId><ArticleId IdType="pubmed">35642476</ArticleId></ArticleIdList></Reference><Reference><Citation>Otto SP, Day T, Arino J, Colijn C, Dushoff J, et al. The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic. Curr Biol. 2021;31:R918–R929. doi: 10.1016/j.cub.2021.06.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2021.06.049</ArticleId><ArticleId IdType="pmc">PMC8220957</ArticleId><ArticleId IdType="pubmed">34314723</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotwa JD, Lobb B, Massé A, Gagnier M, Aftanas P, et al. Genomic and transcriptomic characterization of delta SARS-CoV-2 infection in free-ranging white-tailed deer (Odocoileus virginianus) iScience . 2023;26:108319. doi: 10.1016/j.isci.2023.108319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2023.108319</ArticleId><ArticleId IdType="pmc">PMC10665813</ArticleId><ArticleId IdType="pubmed">38026171</ArticleId></ArticleIdList></Reference><Reference><Citation>Bashor L, Gagne RB, Bosco-Lauth AM, Bowen RA, Stenglein M, et al. SARS-CoV-2 evolution in animals suggests mechanisms for rapid variant selection. Proc Natl Acad Sci U S A. 2021;118:e2105253118. doi: 10.1073/pnas.2105253118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2105253118</ArticleId><ArticleId IdType="pmc">PMC8612357</ArticleId><ArticleId IdType="pubmed">34716263</ArticleId></ArticleIdList></Reference><Reference><Citation>Cele S, Karim F, Lustig G, San JE, Hermanus T, et al. SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape. Cell Host Microbe. 2022;30:154–162. doi: 10.1016/j.chom.2022.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2022.01.005</ArticleId><ArticleId IdType="pmc">PMC8758318</ArticleId><ArticleId IdType="pubmed">35120605</ArticleId></ArticleIdList></Reference><Reference><Citation>Universal Declaration of Human Rights - Wikisource, the free online library.  [9-April-2024]. https://en.wikisource.org/wiki/Universal_Declaration_of_Human_Rights n.d. accessed.</Citation></Reference><Reference><Citation>Murall CL, Fournier E, Galvez JH, N’Guessan A, Reiling SJ, et al. A small number of early introductions seeded widespread transmission of SARS-CoV-2 in Québec, Canada. Genome Med. 2021;13:169. doi: 10.1186/s13073-021-00986-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-021-00986-9</ArticleId><ArticleId IdType="pmc">PMC8550813</ArticleId><ArticleId IdType="pubmed">34706766</ArticleId></ArticleIdList></Reference><Reference><Citation>Otto SP, MacPherson A, Colijn C. Endemic does not mean constant as SARS-CoV-2 continues to evolve. Evolution. 2024;78:1092–1108. doi: 10.1093/evolut/qpae041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/evolut/qpae041</ArticleId><ArticleId IdType="pubmed">38459852</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker SJC, Nfonsam LE, Leto D, Rutherford C, Smieja M, et al. Chronic COVID-19 infection in an immunosuppressed patient shows changes in lineage over time: a case report. Virol J. 2024;21:8. doi: 10.1186/s12985-023-02278-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-023-02278-7</ArticleId><ArticleId IdType="pmc">PMC10768205</ArticleId><ArticleId IdType="pubmed">38178158</ArticleId></ArticleIdList></Reference><Reference><Citation>Isabel S, Abdulnoor M, Boissinot K, Isabel MR, de Borja R, et al. Emergence of a mutation in the nucleocapsid gene of SARS-CoV-2 interferes with PCR detection in Canada. Sci Rep. 2022;12:10867. doi: 10.1038/s41598-022-13995-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13995-4</ArticleId><ArticleId IdType="pmc">PMC9237068</ArticleId><ArticleId IdType="pubmed">35760824</ArticleId></ArticleIdList></Reference><Reference><Citation>The European Respiratory Virus Surveillance Summary (ERVISS)  [8-August-2024]. https://www.ecdc.europa.eu/en/publications-data/european-respiratory-virus-surveillance-summary-erviss n.d. accessed.</Citation></Reference><Reference><Citation>Colijn C, Earn DJ, Dushoff J, Ogden NH, Li M, et al. The need for linked genomic surveillance of SARS-CoV-2. Can Commun Dis Rep . 2022;48:131–139. doi: 10.14745/ccdr.v48i04a03.</Citation><ArticleIdList><ArticleId IdType="doi">10.14745/ccdr.v48i04a03</ArticleId><ArticleId IdType="pmc">PMC9017802</ArticleId><ArticleId IdType="pubmed">35480703</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>